risankizumab,tofacitinib,vedolizumab,azacitidine,ustekinumab,ozanimod,upadacitinib,adalimumab,golimumab,infliximab
abbvie,bms,janssen,takeda,pfizer
['ibd']
the new safety pyramid based on clinical experience of an evolution of therapies as we move forward into the world. #aibd2022 publication to follow! 
Current Associate Staff @ClevelandClinic  Former GI Fellow @BrighamGI and advanced IBD fellow @BMC/@BMCIMres alumni. Passionate about IBD patient care